{
    "nctId": "NCT00248170",
    "briefTitle": "Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer",
    "officialTitle": "Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 4172,
    "primaryOutcomeMeasure": "Disease Free Survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Recent primary surgery for breast cancer\n* Early stage breast cancer\n* Postmenopausal\n* Hormone receptor positive\n* Positive lymph node involvement\n\nExclusion Criteria:\n\n* Metastatic disease\n* Presence of contralateral breast cancer including DCIS\n* Progression\n\nOther protocol-defined inclusion/exclusion criteria may apply.",
    "sex": "FEMALE",
    "minimumAge": "33 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}